Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAD1L1 Antikörper

Rockland 200-301-903 MAD1L1 Reaktivität: Human WB, ELISA, IP Wirt: Maus Monoclonal 9B10 unconjugated
Rockland
Produktnummer ABIN129517
Hersteller Produkt- Nr.: 200-301-903
  • Target Alle MAD1L1 Antikörper anzeigen
    MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))
    Reaktivität
    • 34
    • 15
    • 13
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 31
    • 3
    • 1
    Maus
    Klonalität
    • 32
    • 3
    Monoklonal
    Konjugat
    • 23
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser MAD1L1 Antikörper ist unkonjugiert
    Applikation
    • 25
    • 13
    • 7
    • 6
    • 5
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunoprecipitation (IP)
    Hersteller Produkt- Nr.
    200-301-903
    Hersteller
    Rockland
    Verwendungszweck
    MAD1L1 Antibody
    Kreuzreaktivität (Details)
    This Protein A purified antibody is directed against human MAD1L1 protein.
    Produktmerkmale
    Synonyms: mouse anti-MAD1L1 antibody, Mitotic arrest deficient 1 antibody, Mitotic checkpoint MAD1 protein homolog antibody, Mitotic spindle assembly checkpoint protein MAD1 antibody, PIG9 antibody, Tax binding protein 181 antibody
    Aufreinigung
    The product was purified from tissue culture supernatant by chromatography.
    Sterilität
    Sterile filtered
    Immunogen

    Immunogen: This protein A purified monoclonal antibody was produced by repeated immunizations with full-length recombinant human MAD1L1 protein.

    Immunogen Type: Recombinant Protein

    Klon
    9B10
    Isotyp
    IgG2b kappa
    Top Product
    Discover our top product MAD1L1 Primärantikörper
  • Applikationshinweise

    Application Note: This protein A purified antibody is suitable for use in flow cytometry, immunoprecipitation, immunofluorescence and western blot.  Specific conditions for reactivity should be optimized by the end user. Expect a predominant band at ~ 83 kDa corresponding to full-length protein by western blotting in the appropriate cell lysate or extract.

    Western Blot Dilution: 1:200 - 1:1,000

    Immunoprecipitation Dilution: 1:100

    ELISA Dilution: 1:5,000 - 1:20,000

    Other: User Optimized

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1.0 mg/mL
    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store vial at -20° C prior to opening.  Aliquot contents and freeze at -20° C or below for extended storage.  Avoid cycles of freezing and thawing.  Centrifuge product if not completely clear after standing at room temperature.  This product is stable for several weeks at 4° C as an undiluted liquid.  Dilute only prior to immediate use.
    Haltbarkeit
    12 months
  • Sikorski, Mehta, Inngjerdingen, Thakor, Kling, Kalina, Nyman, Stensland, Zhou, de Souza, Holden, Stuchly, Templin, Lund-Johansen: "A high-throughput pipeline for validation of antibodies." in: Nature methods, Vol. 15, Issue 11, pp. 909-912, (2019) (PubMed).

  • Target
    MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))
    Andere Bezeichnung
    MAD1L1 (MAD1L1 Produkte)
    Hintergrund
    Background: MAD1L1 (also called mitotic spindle assembly checkpoint protein, MAD1A, MAD1-like 1 and HsMAD1) is a component of the spindle-assembly checkpoint that prevents the onset of anaphase until all chromosomes are properly aligned at the metaphase plate. MAD1L1 has a role in the correct positioning of the septum and is required for anchoring MAD2L1 to the nuclear periphery.   MAD1L1 forms a homodimer and also heterodimerizes with MAD2L1 in order to form a tetrameric MAD1L1-MAD2L1 core complex. Perturbation of the original MAD1L1-MAD2L1 structure by the spindle checkpoint may decrease MAD2L1 affinity for MAD1L1. CDC20 can compete with MAD1L1 for MAD2L1 binding, until the attachment and/or tension dampen the checkpoint signal, preventing further release of MAD2L1 on to CDC20.  MAD1L1 is also able to interact with the BUB1/BUB3 complex and the viral Tax protein.   MAD1L1 is a nuclear protein that is seen to move from the beginning to the end of mitosis from a diffusely nuclear distribution to the centrosome, to the spindle midzone and finally to the midbody.  Multiple isoforms may exist for this protein (MAD1L1 and MAD1L2).  MAD1L1 is induced by TP53 and is phosphorylated by BUB1. MAD1L1 is hyperphosphorylated in late S through M phases or after mitotic spindle damage.  Defects in MAD1L1 are involved in the development and/or progression of various types of cancer.
    Gen-ID
    8379
    UniProt
    Q9Y6D9
    Pathways
    M Phase
Sie sind hier:
Kundenservice